Sentinel Cerebral Protection System

FDA 510(k) K192460 · Boston Scientific Corporation

Substantially Equivalent

510(k) numberK192460

Submission

Device name
Sentinel Cerebral Protection System
Applicant
Boston Scientific Corporation
Maple Grove, MN, US
Received
September 9, 2019
Decision date
February 19, 2020
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PUM – Temporary Catheter, Embolic Protection, Transcatheter Intracardiac Procedures
Device class
Class II (moderate risk)
Regulation
21 CFR 870.1251
Specialty
Cardiovascular

Embolic protection for transcatheter intracardiac procedures

Other 510(k)s with product code PUM

510(k)DeviceApplicantDecision
K261715Emboliner Embolic Protection System (EPC-03)PUM · Traditional Emboline, Inc.09/08/2026SE

More from Emboline, Inc.

510(k)DeviceDecision
K262151SpaceOAR Flex™ SystemOVB · Traditional 09/11/2026SE
K262460Rezum SystemKNS · Traditional 09/03/2026SE
K261153LithoVue Elite Digital Flexible Ureteroscope SystemFGB · Traditional 08/26/2026SE
K253692AVVIGO™+ Multi-Modality Guidance SystemDQK · Traditional 08/21/2026SE
K262406EluPro Antibiotic-Eluting BioEnvelopeFTM · Special 08/12/2026SE
K261915Navigator™ Flex Ureteral Access Sheath SetFED · Traditional 08/04/2026SE
K262462TheraSphere 360™ Y-90 Management PlatformLLZ · Special 07/24/2026SE
K262165FARADRIVE™ Steerable Sheath (M004PF21M402)DRA · Special 07/24/2026SE
K261488OBSIDIO Conformable EmbolicKRD · Traditional 07/24/2026SE
K261978WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent SystemESW · Special 07/10/2026SE

Questions and answers

When was Sentinel Cerebral Protection System cleared by the FDA?

Sentinel Cerebral Protection System (K192460) received a 510(k) decision of Substantially Equivalent on February 19, 2020, 163 days after the submission was received.

What is the product code of K192460?

The FDA product code is PUM – Temporary Catheter, Embolic Protection, Transcatheter Intracardiac Procedures, a Class II (moderate risk) device regulated under 21 CFR 870.1251.